WHO-GMP Certified
International quality standards
Pharma

Dapahive M 10/500 ER Tablet is a combination of two antidiabetic medicines used to treat Type 2 diabetes mellitus. It helps control elevated blood sugar levels and supports long-term metabolic stability.
The extended-release (ER) formulation is designed to provide sustained therapeutic action, improving blood glucose control throughout the day.
Effective glycemic control reduces the risk of serious diabetes-related complications, including:
Dapahive M 10/500 ER Tablet should be taken with food and at the same time every day to maintain consistent blood glucose levels and maximize therapeutic effectiveness.
The dosage will be determined by a healthcare professional based on the patient’s condition and response to therapy. Do not discontinue this medicine without medical advice, as stopping treatment may result in increased blood sugar levels and higher complication risk.
This medication is part of a comprehensive diabetes management program that should include:
as advised by a healthcare professional.
Dapahive M 10/500 ER Tablet combines two mechanisms of action to improve glycemic control:
Together, these actions help lower blood sugar levels effectively and maintain long-term metabolic balance in patients with Type 2 diabetes.
This dual mechanism classifies Dapahive M 10/500 ER as a combination oral antidiabetic therapy.
Dapahive M 10/500 ER Tablet should be taken strictly as prescribed by a qualified healthcare professional.
For optimal results:
If you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Consistency is critical for effective long-term diabetes management.
Like all medicines, Dapahive M 10/500 ER Tablet may cause side effects, although not everyone experiences them.
Common side effects may include:
Most side effects are mild and temporary. If the symptoms continue or become more severe, consult a healthcare professional without delay.
Dapahive M 10/500 ER Tablet is manufactured under strict quality control systems and undergoes rigorous testing protocols to ensure safety, consistency, and reliability.
Vivifi Pharma adheres to WHO-GMP certified manufacturing practices aligned with its
corporate responsibility and quality standards.
Vivifi Pharma
A pharmaceutical manufacturer committed to quality, compliance, and global healthcare standards.
Learn more about Vivifi Pharma
This information is intended for educational purposes only and should not be considered medical advice. Always consult a healthcare professional before using any medication.
1. What is Dapahive – M 10/500 ER Tablet used for?
Dapahive – M 10/500 ER Tablet is prescribed for the management of Type 2 diabetes mellitus. It helps control high blood sugar levels and supports long-term reduction of diabetes-related complications when used as part of a comprehensive treatment plan.
2. What medicines are present in Dapahive – M 10/500 ER?
This tablet combines Dapagliflozin and Metformin. Dapagliflozin removes excess glucose through urine, while Metformin improves insulin sensitivity and reduces glucose production by the liver.
3. Why should Dapahive – M 10/500 ER be taken with food?
Taking it with food helps reduce the chances of stomach-related side effects such as nausea or diarrhea, particularly due to the Metformin component. It also supports better tolerance of the extended-release formulation.
4. Can Dapahive – M 10/500 ER cause low blood sugar?
On its own, the risk of hypoglycemia is low. However, the risk may increase when used together with insulin or other antidiabetic medicines. Patients should monitor blood glucose levels regularly and follow their doctor’s guidance.
International quality standards
Rigorous testing protocols